Novel radiopharmaceutical therapy offers powerful treatment option for aggressive neuroendocrine tumors
by Society of Nuclear Medicine and Molecular ImagingAn example of partial response. 58-year-old patient with neuroendocrine neoplasm of the pancreas with hepatic and bone metastases. Previously treate
Updated on: August 14,2026
Novel radiopharmaceutical therapy offers powerful treatment option for aggressive neuroendocrine tumors
by Society of Nuclear Medicine and Molecular ImagingAn example of partial response. 58-year-old patient with neuroendocrine neoplasm of the pancreas with hepatic and bone metastases. Previously treate
Updated on:August 14,2026
